Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/
2008 National Healthcare Quality & Disparities Reports

Table 5_2_3.1
Adult patients with HIV and CD4 count <50 who received Mycobacterium avium complex (MAC) prophylaxis,a United States, 2003 and 2005
Population group 2005 2003
Sample size Percent SE Sample size Percent SE
Total 915 87.1 1.1 957 84.3 1.2
Age 18–44 624 86.1 1.4 672 85.6 1.4
45 and over 291 89.3 1.8 285 81.4 2.3
Race Non-Hispanic, White 187 83.4 2.7 191 81.2 2.8
Non-Hispanic, Black 545 87.2 1.4 573 85.5 1.5
Hispanic 167 90.4 2.3 177 84.2 2.8
Other * * * * * *
Gender Male 667 87.7 1.3 724 84.3 1.4
Female 238 85.3 2.3 233 84.5 2.4
Health insurance Private 73 90.4 3.5 60 85.0 4.6
Medicaid/dual eligible 364 88.7 1.7 410 86.8 1.7
Medicare 151 81.5 3.2 127 82.7 3.4
Other/uninsured 159 88.1 2.6 151 86.8 2.8

a For HIV patients having at least two CD4 tests < 50 during the year.

* - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: MAC: Mycobacterium avium complex; SE: standard error.

Source: Agency for Healthcare Research and Quality, Center for Delivery, Organization and Markets, HIV Research Network.

 

AHRQAdvancing Excellence in Health Care